Echopoint Medical's iKor™ platform utilizes optical sensing technology to provide real-time coronary physiology assessments, enabling interventional cardiologists to diagnose and treat patients with ischemia and no obstructive coronary artery disease. This streamlined approach enhances therapy guidance within existing workflows, improving patient outcomes in cases of ischemia without visible blockages.
Funding
$9.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
UTFounders
Product
Problem
Interventional cardiologists face challenges in accurately diagnosing and treating patients with chest pain who exhibit ischemia but have no obstructive coronary artery disease (INOCA). Current diagnostic methods may not provide sufficient real-time physiological data to guide therapy effectively in these cases.
Solution
Echopoint Medical's iKor™ platform offers a solution by utilizing optical sensing technology to deliver real-time coronary physiology assessments. This platform enables interventional cardiologists to diagnose and guide therapy for patients with ischemia and no obstructive coronary artery disease (INOCA) using a single device integrated into their existing workflow. The iKor™ platform aims to improve patient outcomes by providing comprehensive physiological data that supports precision interventions.
Target Audience
The primary target audience includes interventional cardiologists who treat patients with chest pain, specifically those with ischemia and no obstructive coronary artery disease (INOCA).
Features
- Optical sensing technology for real-time coronary physiology assessments.
- Single-device integration into existing interventional cardiology workflows.
- Designed for diagnosing and treating patients with ischemia and no obstructive coronary artery disease (INOCA).